Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

A Randomized Trial of Bevacizumab, an Anti–Vascular Endothelial Growth Factor Antibody, for Metastatic Renal Cancer

PaperCitations, authors & open-access status

A Randomized Trial of Bevacizumab, an Anti–Vascular Endothelial Growth Factor Antibody, for Metastatic Renal Cancer is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 2,707 citations, 2003 year and bronze oa status.

2,707
Citations
2003
Year
bronze
OA Status

Related on ScholarIQ

James Chih‐Hsin Yang
Author
Seth M. Steinberg
Author
New England Journal of Medicine
Journal
Renal cell carcinoma treatment
Topic
Renal cell carcinoma treatment
Topic
Angiogenesis and VEGF in Cancer
Topic
470M+ articles · free account